The latest report by IMARC Group, titled “Cell Counting Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, offers a comprehensive analysis of the industry, which comprises insights on the global cell counting market report. The global market size reached US$ 10.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.5 Billion by 2028, exhibiting a growth rate (CAGR) of 6.7% during 2023-2028.
Cell counting is an advanced technique for analyzing cells or micelles in blood or other body fluids. Various instruments are used for cell counting, including hemocytometers, spectrophotometers, flow cytometers, and automated cell counters. This technique is widely used to classify cell types and detect diseases through probes, aiding in the development of the best treatment plan for the patient. It also assists in understanding the structure and composition of cells for chromosome analysis, protein expression, cancer diagnosis, and hematological malignancies. As a result, cell counting finds extensive applications in hospitals, diagnostic laboratories, research and academic institutes, and pharmaceutical and biotechnology companies across the globe.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/cell-counting-market/requestsample
Cell Counting Market Trends and Drivers:
The global cell counting market is primarily driven by the rising prevalence of chronic diseases, such as cancer, Alzheimer’s, and HIV-AIDS. Moreover, the surging adoption of cell counting instruments across various medical fields, such as pathology, immunology, and molecular biology, for developing advanced therapeutics is positively influencing market growth. Additionally, the increasing use of cell counting to identify primary tumors, circulating tumors, and metastatic tumors has catalyzed market growth. Furthermore, the growing awareness about numerous benefits of cell counting, including immunophenotyping, cell sorting, and intracellular calcium flux, has augmented the product demand. Other factors, including rising adoption of stem cell therapy, increasing government initiatives to support stem cell research, and the introduction of automated product variants, are also anticipated to fuel the market growth.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product Type:
- Consumables
- Reagents
- Assay Kits
- Microplates
- Accessories
- Instruments
- Spectrophotometers
- Flow Cytometers
- Hematology Analyzers
- Cell Counters
Breakup by End User:
- Hospitals and Diagnostic Laboratories
- Research and Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Others
Regional Insights:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Competitive Landscape with Key Players:
- Agilent Technologies Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- F. Hoffmann-La Roche Ltd. (Roche Holding AG).
- Merck & Co. Inc.
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
